25 Nov Pathway to Prevention study of the development of type 1 diabetes
This is the screening part of the study, in which a simple blood test is done to screen for the presence of diabetes-related antibodies.
If antibodies are confirmed to be present, participants will be invited to join the monitoring part of the study and have additional testing. People who are found to be at moderate to high risk of developing type 1 diabetes may be eligible to participate in a prevention trial.
TrialNet is an international network dedicated to the study, prevention and early treatment of type 1 diabetes. TrialNet sites are located throughout the United States, Canada, Finland, United Kingdom, Italy, Australia, and New Zealand.
– Individuals 2.5 to 45 years old who have an immediate family member with type 1 diabetes (such as a child, parent, or sibling
– Individuals 2.5 to 20 years old who have an extended family member with type 1 diabetes (such as a cousin, niece, nephew, aunt, uncle, grandparent, or half-sibling)
Additional Study Details
Full Study Title
Natural History Study of the Development of Type 1 Diabetes
Carla Greenbaum, MD
Accepts Healthy Volunteers?
Benaroya Research Institute
1201 Ninth Avenue
Seattle, Washington 98101
Use the link below to send a message to the study coordinator, or call the number above to speak directly with a study representative.